Trevi Therapeutics (TRVI) Institutional Ownership $14.18 +0.30 (+2.13%) As of 03:26 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)CurrentInstitutional OwnershipPercentage95.76%Number ofInstitutional Buyers(last 12 months)114TotalInstitutional Inflows(last 12 months)$352.54MNumber ofInstitutional Sellers(last 12 months)52TotalInstitutional Outflows(last 12 months)$236.18M Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TRVI Institutional Buying and Selling by Quarter Trevi Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE1,216,955$14.52M0.0%+11.2%0.857% 5/18/2026 Rubric Capital Management LP3,712,373$44.29M0.5%-1.4%2.615% 5/16/2026 The Manufacturers Life Insurance Company 43,561$520K0.0%+55.9%0.031% 5/16/2026 Orbimed Advisors LLC2,454,400$29.28M0.5%-23.1%1.729% 5/15/2026 Octagon Capital Advisors LP1,485,000$17.72M2.0%-47.2%1.046% 5/15/2026 Affinity Asset Advisors LLC2,000,172$23.86M1.2%-7.0%1.409% 5/14/2026 Siren L.L.C.1,786,867$21.32M0.6%-21.9%1.259% 5/14/2026 Sei Investments Co.78,222$933K0.0%-47.1%0.055% 5/7/2026 Dimensional Fund Advisors LP16,101$192K0.0%-55.9%0.013% 5/7/2026 AlphaCentric Advisors LLC23,970$286K0.3%+5.7%0.019% Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/7/2026 KBC Group NV2,464$29K0.0%N/A0.002% 5/4/2026 Emerald Mutual Fund Advisers Trust1,262,492$15.06M0.7%-0.8%0.982% 5/4/2026 Emerald Advisers LLC1,839,566$21.95M0.7%-2.8%1.431% 5/1/2026 Fifth Third Bancorp128,325$1.53M0.0%N/A0.100% 5/1/2026 Candriam S.C.A.773,620$9.23M0.0%N/A0.602% 4/30/2026 Hsbc Holdings PLC17,034$205K0.0%N/A0.013% 4/27/2026 Simplify Asset Management Inc.65,412$780K0.0%N/A0.051% 4/25/2026 Strs Ohio12,800$153K0.0%-46.0%0.010% 4/24/2026 Peregrine Capital Management LLC530,451$6.33M0.2%+4.5%0.413% 4/22/2026 Pictet Asset Management Holding SA1,706,048$20.35M0.0%+11.4%1.327% 4/21/2026 Maltin Wealth Management Inc.10,560$126K0.0%N/A0.008% 4/20/2026 Hilton Head Capital Partners LLC4,250$51K0.0%+32.6%0.003% 4/16/2026 SG Americas Securities LLC28,051$335K0.0%-77.5%0.022% 4/16/2026 Diversified Trust Co23,477$280K0.0%+11.9%0.018% 3/3/2026 Caitong International Asset Management Co. Ltd4,022$50K0.0%N/A0.003% 2/26/2026 Seven Fleet Capital Management LP7,110$89K0.1%N/A0.006% 2/19/2026 Invesco Ltd.498,926$6.25M0.0%+3.3%0.389% 2/18/2026 KVP Capital Advisors LP414,000$5.18M5.0%N/A0.323% 2/18/2026 XTX Topco Ltd83,818$1.05M0.0%N/A0.065% 2/18/2026 Wellington Management Group LLP3,403,990$42.62M0.0%+4.6%2.655% 2/18/2026 Tudor Investment Corp ET AL68,481$857K0.0%N/A0.053% 2/18/2026 Sphera Funds Management LTD.598,534$7.49M1.4%-22.6%0.467% 2/18/2026 Superstring Capital Management LP148,292$1.86M1.0%N/A0.116% 2/18/2026 Orbimed Advisors LLC3,190,700$39.95M0.8%-3.6%2.488% 2/18/2026 Opaleye Management Inc.345,100$4.32M0.6%-11.5%0.269% 2/18/2026 Millennium Management LLC570,226$7.14M0.0%-21.6%0.445% 2/18/2026 Artia Global Partners LP2,013,602$25.21M3.5%+0.7%1.570% 2/18/2026 Balyasny Asset Management L.P.174,641$2.19M0.0%-72.1%0.136% 2/17/2026 Logos Global Management LP1,550,000$19.41M1.2%-29.5%1.209% 2/17/2026 Viking Global Investors LP3,198,644$40.05M0.1%-37.6%2.494% I was right about SpaceX (Ad)Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.See how to claim your stake in SpaceX before the public can2/17/2026 AQR Capital Management LLC29,202$366K0.0%-31.8%0.023% 2/17/2026 Abel Hall LLC10,191$128K0.0%N/A0.008% 2/17/2026 MPM Bioimpact LLC3,287,087$41.15M4.7%-3.5%2.563% 2/17/2026 Price T Rowe Associates Inc. MD50,273$630K0.0%+7.3%0.039% 2/17/2026 California State Teachers Retirement System83,788$1.05M0.0%+2.6%0.065% 2/17/2026 Diadema Partners LP97,184$1.22M0.2%+13.2%0.076% 2/17/2026 Russell Investments Group Ltd.59,444$744K0.0%+5.3%0.046% 2/17/2026 State of Wisconsin Investment Board120,566$1.51M0.0%-2.2%0.094% 2/17/2026 Fred Alger Management LLC157,980$1.98M0.0%-17.3%0.123% 2/17/2026 Royal Bank of Canada33,119$415K0.0%-80.4%0.026% 2/17/2026 Persistent Asset Partners Ltd45,830$574K0.3%+132.8%0.036% 2/16/2026 Verition Fund Management LLC32,119$402K0.0%N/A0.025% 2/16/2026 Panagora Asset Management Inc.693,001$8.68M0.0%+21.5%0.540% 2/16/2026 Kennedy Capital Management LLC56,269$704K0.0%+2.4%0.044% 2/16/2026 Dymon Asia Capital Singapore PTE. LTD.20,000$250K0.0%N/A0.016% 2/16/2026 Eventide Asset Management LLC2,622,306$32.83M0.5%+89.8%2.045% 2/16/2026 Barclays PLC582,653$7.30M0.0%+168.6%0.454% 2/13/2026 Marshall Wace LLP4,580,548$57.35M0.1%-5.4%3.572% 2/13/2026 The Manufacturers Life Insurance Company 27,937$350K0.0%-5.7%0.022% 2/13/2026 Affinity Asset Advisors LLC2,150,172$26.92M1.5%-23.2%1.677% 2/13/2026 Rubric Capital Management LP3,766,749$47.16M0.6%-55.9%2.937% 2/13/2026 Stifel Financial Corp28,288$354K0.0%+23.5%0.022% 2/13/2026 Hudson Bay Capital Management LP75,000$939K0.0%N/A0.058% 2/13/2026 Rafferty Asset Management LLC16,499$207K0.0%+21.6%0.013% 2/13/2026 Siren L.L.C.2,286,867$28.63M0.9%-9.9%1.783% 2/13/2026 Charles Schwab Investment Management Inc.836,800$10.48M0.0%+3.8%0.653% 2/13/2026 State Street Corp2,435,000$30.49M0.0%+9.7%1.899% 2/13/2026 Vontobel Holding Ltd.10,764$135K0.0%-50.8%0.008% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC140,733$1.76M0.0%+20.8%0.110% 2/13/2026 Wells Fargo & Company MN101,279$1.27M0.0%+81.9%0.079% 2/12/2026 HRT Financial LP125,104$1.57M0.0%N/A0.098% 2/12/2026 Dimensional Fund Advisors LP36,510$457K0.0%-11.9%0.028% 2/12/2026 AlphaCentric Advisors LLC22,667$284K0.3%N/A0.018% 2/12/2026 Informed Momentum Co LLC541,242$6.78M0.8%-1.5%0.422% 2/12/2026 Steward Partners Investment Advisory LLC44,095$552K0.0%+39.6%0.034% 2/12/2026 Campbell & CO Investment Adviser LLC71,097$890K0.0%+185.7%0.055% 2/12/2026 Swiss National Bank168,200$2.11M0.0%+4.0%0.131% 2/11/2026 Deutsche Bank AG70,833$887K0.0%+37.2%0.055% 2/11/2026 Fox Run Management L.L.C.31,346$392K0.1%N/A0.024% 2/11/2026 LPL Financial LLC52,960$663K0.0%+30.9%0.041% 2/11/2026 Erste Asset Management GmbH90,000$1.15M0.0%N/A0.070% 2/11/2026 Hilton Head Capital Partners LLC3,206$40K0.0%N/A0.003% 2/11/2026 BIT Capital GmbH130,000$1.63M0.1%+1,829.1%0.101% 2/10/2026 Goldman Sachs Group Inc.1,056,891$13.23M0.0%+34.2%0.824% 2/10/2026 AXQ Capital LP22,204$278K0.1%+43.0%0.017% 2/10/2026 Intech Investment Management LLC29,070$364K0.0%+14.8%0.023% 2/9/2026 Kingsview Wealth Management LLC10,638$133K0.0%N/A0.008% 2/9/2026 Geode Capital Management LLC2,412,885$30.21M0.0%+8.6%1.882% 2/9/2026 Flputnam Investment Management Co.1,053,427$13.19M0.2%+0.5%0.822% 2/9/2026 Sectoral Asset Management Inc.84,255$1.06M0.8%-20.5%0.066% Your book is inside (Ad)The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.Download your copy now.2/6/2026 ProShare Advisors LLC22,269$279K0.0%+15.3%0.017% 2/4/2026 Nan Fung Trinity HK Ltd.917,450$11.49M0.9%+924.2%0.715% 2/3/2026 F m Investments LLC241,483$3.02M0.1%N/A0.188% 2/2/2026 Strs Ohio23,700$297K0.0%-26.6%0.018% 2/2/2026 Oppenheimer & Co. Inc.100,698$1.26M0.0%+2.1%0.079% 1/30/2026 Chapin Davis Inc.20,100$252K0.1%-42.7%0.016% 1/29/2026Comerica Bank83,027$1.04M0.0%+19,481.8%0.065% 1/29/2026 Pictet Asset Management Holding SA1,532,013$19.18M0.0%+13,507.0%1.195% 1/29/2026 UBS Group AG274,628$3.44M0.0%-8.0%0.214% 1/29/2026Vanguard Group Inc.6,434,655$80.56M0.0%+10.4%5.018% TRVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRVI shares? During the previous two years, 172 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($80.56M), Frazier Life Sciences Management L.P. ($64.53M), Marshall Wace LLP ($57.35M), Vivo Capital LLC ($46.62M), Rubric Capital Management LP ($44.29M), Wellington Management Group LLP ($42.62M), and MPM Bioimpact LLC ($41.15M).Learn more on Trevi Therapeutics' institutional investors. What percentage of Trevi Therapeutics' stock is owned by institutional investors? 95.76% of Trevi Therapeutics' stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings. Which institutional investors have been buying Trevi Therapeutics' stock? Of the 153 institutional investors that purchased Trevi Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alliancebernstein L.P. ($4.27M), Point72 Asset Management L.P. ($4.15M), Rubric Capital Management LP ($3.99M), Octagon Capital Advisors LP ($3.67M), Viking Global Investors LP ($3.59M), Vivo Capital LLC ($3.48M), and Wellington Management Group LLP ($3.36M). How much institutional buying is happening at Trevi Therapeutics? Institutional investors have bought a total of 42,980,152 shares in the last 24 months. This purchase volume represents approximately $352.54M in transactions. Which of Trevi Therapeutics' major shareholders have been selling company stock? Of the 52 institutional investors that sold Trevi Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rubric Capital Management LP ($4.82M), Woodline Partners LP ($3.95M), Viking Global Investors LP ($3.62M), Octagon Capital Advisors LP ($1.33M), MAI Capital Management ($1.29M), Orbimed Advisors LLC ($854K), and Affinity Asset Advisors LLC ($799.83K). How much institutional selling is happening at Trevi Therapeutics? Institutional investors have sold a total of 22,819,557 shares in the last 24 months. This volume of shares sold represents approximately $236.18M in transactions. Related Companies IBRX Major Shareholders NUVL Major Shareholders PCVX Major Shareholders KYMR Major Shareholders MIRM Major Shareholders QGEN Major Shareholders SYRE Major Shareholders RYTM Major Shareholders TGTX Major Shareholders PTGX Major Shareholders This page (NASDAQ:TRVI) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
